Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

MetaVia Inc.

NASDAQ: MTVA · Life Sciences · 8 alerts · CIK 1638287

Share price
$1.21Close, Nov 16
Market cap
$8.13M
Shares outstanding
6.74MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All MetaVia Inc. filings on SEC EDGAR ↗

9:01 AM ET 8-K
Business Update

MetaVia Business Update

MetaVia announced that an abstract for its Phase 1 clinical trial of DA-1726, a dual GLP-1 and glucagon receptor agonist, has been accepted for an oral presentation at the Precision Liver Symposium 2026. The presentation, scheduled for November 4, 2026, will highlight data regarding weight loss and reduction in MRI-PDFF (liver fat) in patients. While the filing mentions previous trial findings, it does not disclose the specific new data points or results that will be presented at the upcoming conference.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.